NCT00398853View on ClinicalTrials.gov

Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

April 30, 2009

Study Completion Date

June 30, 2009

Conditions
Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

chromium picolinate 1000 mcg daily vs placebo

chromium picolinate 1000 mcg daily vs placebo

OTHER

Placebo

Placebo

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT00398853 - Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes | Biotech Hunter | Biotech Hunter